New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers

Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAbout 53% of lung cancers in females are not attributable to smoking worldwide and a new model presented today
World medicine December 15,2023
Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers

Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAbout 53% of lung cancers in females are not attributable to smoking worldwide and a new model presented today
World medicine December 15,2023
Liver cancer's supercharged metabolism offers a new treatment strategy, study suggests

Liver cancer's supercharged metabolism offers a new treatment strategy, study suggests

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainLiver cancer's rapid growth leads to a vulnerability in its energy-production and cell-buildin
World medicine December 15,2023
Liver cancer's supercharged metabolism offers a new treatment strategy, study suggests

Liver cancer's supercharged metabolism offers a new treatment strategy, study suggests

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainLiver cancer's rapid growth leads to a vulnerability in its energy-production and cell-buildin
World medicine December 15,2023
3D bioprinting platform replicates patient-specific tumors

3D bioprinting platform replicates patient-specific tumors

byUniversity of BristolFeatures of bioprinted tumor spheroids. (a) Growth of all four cancer cell lines (pink: LS174T, purple: SW620, blue: SW480, yellow: CACO2), measured 7, 9 and 11 d after bi
World medicine December 15,2023
3D bioprinting platform replicates patient-specific tumors

3D bioprinting platform replicates patient-specific tumors

byUniversity of BristolFeatures of bioprinted tumor spheroids. (a) Growth of all four cancer cell lines (pink: LS174T, purple: SW620, blue: SW480, yellow: CACO2), measured 7, 9 and 11 d after bi
World medicine December 15,2023
Earlier detection of a malignancy in neurofibromatosis type 1

Earlier detection of a malignancy in neurofibromatosis type 1

byChildren's Hospital BostonCredit: Pixabay/CC0 Public DomainNeurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3,000 individuals, and people with NF1 are at greate
World medicine December 15,2023
Earlier detection of a malignancy in neurofibromatosis type 1

Earlier detection of a malignancy in neurofibromatosis type 1

byChildren's Hospital BostonCredit: Pixabay/CC0 Public DomainNeurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3,000 individuals, and people with NF1 are at greate
World medicine December 15,2023
Smart contact lenses for cancer diagnostics and screening

Smart contact lenses for cancer diagnostics and screening

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a contact lens that can capture tears for the detection of exosome
World medicine December 15,2023
Smart contact lenses for cancer diagnostics and screening

Smart contact lenses for cancer diagnostics and screening

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a contact lens that can capture tears for the detection of exosome
World medicine December 15,2023
In a world full of 3D models, researchers build a new one for leukemia

In a world full of 3D models, researchers build a new one for leukemia

byUniversity of Rochester Medical CenterBen Frisch, PhD, holds the bone-marrow-on-chip device in his lab. Credit: University of Rochester Medical CenterA Wilmot Cancer Institute scientist publis
World medicine December 15,2023
In a world full of 3D models, researchers build a new one for leukemia

In a world full of 3D models, researchers build a new one for leukemia

byUniversity of Rochester Medical CenterBen Frisch, PhD, holds the bone-marrow-on-chip device in his lab. Credit: University of Rochester Medical CenterA Wilmot Cancer Institute scientist publis
World medicine December 15,2023
Protein that may predict future diabetes risk and death from cancer identified

Protein that may predict future diabetes risk and death from cancer identified

byDiabetologiaNew research, published inDiabetologia, suggests that people with elevated levels of the protein prostasin (mainly found in epithelial cells which line the surfaces and organ
World medicine December 15,2023
Protein that may predict future diabetes risk and death from cancer identified

Protein that may predict future diabetes risk and death from cancer identified

byDiabetologiaNew research, published inDiabetologia, suggests that people with elevated levels of the protein prostasin (mainly found in epithelial cells which line the surfaces and organ
World medicine December 15,2023
Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping

Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping

by International Association for the Study of Lung CancerA study presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinical-relevant intertumoral heterogeneity
World medicine December 15,2023
Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping

Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping

by International Association for the Study of Lung CancerA study presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinical-relevant intertumoral heterogeneity
World medicine December 15,2023
Sugemalimab: safe and effective consolidation therapy for patients with unresectable Stage III NSCLC

Sugemalimab: safe and effective consolidation therapy for patients with unresectable Stage III NSCLC

by International Association for the Study of Lung CancerThe human monoclonal antibody sugemalimab is a safe and effective consolidation therapy for patients with unresectable stage III non-small cell
World medicine December 15,2023
Sugemalimab: safe and effective consolidation therapy for patients with unresectable Stage III NSCLC

Sugemalimab: safe and effective consolidation therapy for patients with unresectable Stage III NSCLC

by International Association for the Study of Lung CancerThe human monoclonal antibody sugemalimab is a safe and effective consolidation therapy for patients with unresectable stage III non-small cell
World medicine December 15,2023
Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with NSCLC

Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with NSCLC

by International Association for the Study of Lung CancerFollowing concurrent chemoradiation for unresectable stage III non-small cell lung cancer, both nivolumab alone and nivolumab and ipilimumab co
World medicine December 15,2023
Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with NSCLC

Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with NSCLC

by International Association for the Study of Lung CancerFollowing concurrent chemoradiation for unresectable stage III non-small cell lung cancer, both nivolumab alone and nivolumab and ipilimumab co
World medicine December 15,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com